PAQR7
PAQR7[edit | edit source]
PAQR7 (Progestin and AdipoQ Receptor family member 7) is a protein that in humans is encoded by the PAQR7 gene. This protein is part of the progestin and adipoQ receptor (PAQR) family, which is involved in various cellular processes, including metabolism and reproductive functions.
Structure[edit | edit source]
PAQR7 is a member of the membrane receptor family characterized by a seven-transmembrane domain structure. This structure is similar to that of G protein-coupled receptors (GPCRs), although PAQR7 and its family members are not classical GPCRs. The protein is embedded in the cell membrane, allowing it to interact with extracellular signals and transmit them into the cell.
Function[edit | edit source]
PAQR7 is primarily known for its role in mediating the effects of progestins, which are a group of steroid hormones. These hormones are crucial for regulating the menstrual cycle, maintaining pregnancy, and influencing other reproductive processes. PAQR7 is thought to act as a membrane-bound receptor for these hormones, facilitating rapid non-genomic signaling pathways.
In addition to its role in reproductive biology, PAQR7 has been implicated in metabolic processes. It is believed to interact with adiponectin, a hormone involved in regulating glucose levels and fatty acid breakdown. This interaction suggests a potential role for PAQR7 in metabolic homeostasis and energy balance.
Expression[edit | edit source]
The expression of PAQR7 is tissue-specific, with high levels found in reproductive tissues such as the ovaries and uterus. It is also expressed in other tissues, including the brain and adipose tissue, indicating a broader physiological role.
Clinical Significance[edit | edit source]
Alterations in PAQR7 expression or function have been associated with various clinical conditions. For example, dysregulation of PAQR7 may contribute to reproductive disorders, such as infertility or polycystic ovary syndrome (PCOS). Additionally, given its role in metabolism, PAQR7 may be involved in metabolic disorders like obesity and type 2 diabetes.
Research is ongoing to better understand the precise mechanisms by which PAQR7 influences these conditions and to explore its potential as a therapeutic target.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD